US5795714A
(en)
*
|
1992-11-06 |
1998-08-18 |
Trustees Of Boston University |
Method for replicating an array of nucleic acid probes
|
US6436635B1
(en)
*
|
1992-11-06 |
2002-08-20 |
Boston University |
Solid phase sequencing of double-stranded nucleic acids
|
US6194144B1
(en)
*
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
US5547835A
(en)
|
1993-01-07 |
1996-08-20 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
FR2703693B1
(fr)
*
|
1993-04-06 |
1995-07-13 |
Pasteur Institut |
Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic.
|
US20020037517A1
(en)
*
|
1993-05-28 |
2002-03-28 |
Hutchens T. William |
Methods for sequencing biopolymers
|
US6020208A
(en)
*
|
1994-05-27 |
2000-02-01 |
Baylor College Of Medicine |
Systems for surface-enhanced affinity capture for desorption and detection of analytes
|
PT700521E
(pt)
|
1993-05-28 |
2003-10-31 |
Baylor College Medicine |
Metodo e espectrometro de massa para dessorcao e ionizacao de analitos
|
EP0765401B1
(de)
*
|
1993-11-17 |
2001-02-21 |
Amersham Pharmacia Biotech UK Limited |
Verfahren zur massenspektroskopischen sequenzanalyse einer nukleinsäure mittels primerverlängerung
|
SI9400107A
(en)
|
1994-03-02 |
1995-10-31 |
Lek Tovarna Farmacevtskih |
New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
|
EP0754046A1
(de)
*
|
1994-04-04 |
1997-01-22 |
FREEMAN, William R. |
Verwendung der phosphonylmethoxyalkyl-nukleoside zur behandlung des erhöhten innenaugendrucks
|
DE69529571T2
(de)
*
|
1994-11-07 |
2004-01-29 |
Rikagaku Kenkyusho |
Verfahren zur bestimmung einer dns nukleotid sequenz
|
GB9504598D0
(en)
*
|
1995-03-03 |
1995-04-26 |
Imp Cancer Res Tech |
Method of nucleic acid analysis
|
SI9500074A
(en)
*
|
1995-03-10 |
1996-10-31 |
Lek Tovarna Farmacevtskih |
Process for preparation of alkani salts of clavulanic acid.
|
US6428955B1
(en)
|
1995-03-17 |
2002-08-06 |
Sequenom, Inc. |
DNA diagnostics based on mass spectrometry
|
AU769545B2
(en)
*
|
1995-03-17 |
2004-01-29 |
Sequenom, Inc. |
DNA diagnostics based on mass spectrometry
|
US7803529B1
(en)
|
1995-04-11 |
2010-09-28 |
Sequenom, Inc. |
Solid phase sequencing of biopolymers
|
JPH11503611A
(ja)
*
|
1995-04-11 |
1999-03-30 |
トラスティーズ・オブ・ボストン・ユニバーシティ |
生体高分子の固相配列決定法
|
US20060063193A1
(en)
*
|
1995-04-11 |
2006-03-23 |
Dong-Jing Fu |
Solid phase sequencing of double-stranded nucleic acids
|
US5750341A
(en)
*
|
1995-04-17 |
1998-05-12 |
Lynx Therapeutics, Inc. |
DNA sequencing by parallel oligonucleotide extensions
|
US5700642A
(en)
*
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
US5830655A
(en)
*
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
US6146854A
(en)
*
|
1995-08-31 |
2000-11-14 |
Sequenom, Inc. |
Filtration processes, kits and devices for isolating plasmids
|
WO1997012897A1
(en)
*
|
1995-10-03 |
1997-04-10 |
The Penn State Research Foundation |
Method to identify a surface-bound molecule
|
DE19543065C2
(de)
*
|
1995-11-09 |
2002-10-31 |
Gag Bioscience Gmbh Zentrum Fu |
Verfahren zur Genomanalyse und Mittel zur Durchführung des Verfahrens
|
WO1997027325A2
(en)
*
|
1996-01-23 |
1997-07-31 |
Rapigene, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
US6027890A
(en)
|
1996-01-23 |
2000-02-22 |
Rapigene, Inc. |
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
|
US6312893B1
(en)
|
1996-01-23 |
2001-11-06 |
Qiagen Genomics, Inc. |
Methods and compositions for determining the sequence of nucleic acid molecules
|
US6613508B1
(en)
*
|
1996-01-23 |
2003-09-02 |
Qiagen Genomics, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
ES2144846T5
(es)
*
|
1996-01-23 |
2006-07-16 |
Qiagen Genomics, Inc. |
Metodos y composiciones para determinar la secuencia de moleculas de acidos nucleicos.
|
EP0992511B1
(de)
*
|
1996-01-23 |
2009-03-11 |
Operon Biotechnologies, Inc. |
Verfahren und Zusammensetzungen zur Bestimmung von Sequenzen von Nukleinsäure-Molekülen
|
EP0886681A1
(de)
*
|
1996-03-04 |
1998-12-30 |
Genetrace Systems, Inc. |
Verfahren zur suche von nukleinsäuren mit massenspektroskopie
|
AU2217597A
(en)
*
|
1996-03-18 |
1997-10-22 |
Sequenom, Inc. |
Dna sequencing by mass spectrometry
|
AU2462497A
(en)
|
1996-04-17 |
1997-11-19 |
Hubert Koster |
A combinatorial protecting group strategy for multifunctional molecules
|
US5928906A
(en)
*
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
US6022688A
(en)
*
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US5780232A
(en)
*
|
1996-05-28 |
1998-07-14 |
Atom Sciences, Inc. |
DNA sequencing, mapping, and diagnostic processes using hybridization and stable isotope labels of DNA
|
DE19629281A1
(de)
*
|
1996-07-19 |
1998-01-29 |
Bruker Franzen Analytik Gmbh |
Verfahren zur Vorbereitung von Biomaterialproben für die massenspektrometrische Analyse von Genmerkmalen
|
DE19629543C2
(de)
*
|
1996-07-22 |
1999-02-11 |
Immuno Ag |
Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
|
US5821060A
(en)
*
|
1996-08-02 |
1998-10-13 |
Atom Sciences, Inc. |
DNA sequencing, mapping, and diagnostic processes using hybridization chips and unlabeled DNA
|
US5902879A
(en)
*
|
1996-08-05 |
1999-05-11 |
Fidelity Systems, Inc. |
Methoxyoxalamido and succinimido precursors for nucleophilic addition to nucleosides, nucleotides and oligonucleotides
|
US5777324A
(en)
|
1996-09-19 |
1998-07-07 |
Sequenom, Inc. |
Method and apparatus for maldi analysis
|
WO1998012355A1
(en)
*
|
1996-09-19 |
1998-03-26 |
Genetrace Systems |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5965363A
(en)
*
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5885775A
(en)
*
|
1996-10-04 |
1999-03-23 |
Perseptive Biosystems, Inc. |
Methods for determining sequences information in polynucleotides using mass spectrometry
|
DK0937096T3
(da)
|
1996-11-06 |
2004-06-14 |
Sequenom Inc |
Fremgangsmåde til massespektrometri-analyse
|
US6024925A
(en)
|
1997-01-23 |
2000-02-15 |
Sequenom, Inc. |
Systems and methods for preparing low volume analyte array elements
|
US7285422B1
(en)
|
1997-01-23 |
2007-10-23 |
Sequenom, Inc. |
Systems and methods for preparing and analyzing low volume analyte array elements
|
US6140053A
(en)
*
|
1996-11-06 |
2000-10-31 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
DE19782095T1
(de)
*
|
1996-11-06 |
2000-03-23 |
Sequenom Inc |
DNA-Diagnose auf der Basis von Massenspektrometrie
|
US6133436A
(en)
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
US6110676A
(en)
*
|
1996-12-04 |
2000-08-29 |
Boston Probes, Inc. |
Methods for suppressing the binding of detectable probes to non-target sequences in hybridization assays
|
DE69735445T2
(de)
|
1996-12-10 |
2006-08-10 |
Sequenom, Inc., San Diego |
Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
|
US6699668B1
(en)
|
1997-01-15 |
2004-03-02 |
Xzillion Gmbh & Co. |
Mass label linked hybridisation probes
|
DE69838519T2
(de)
*
|
1997-01-15 |
2008-07-03 |
Xzillion Gmbh & Co. Kg |
Massenmarkierte Hybridisierungssonden
|
WO1998033808A2
(en)
*
|
1997-02-04 |
1998-08-06 |
Hubert Koster |
A reversible stoichiometric process for conjugating biomolecules
|
CA2281205A1
(en)
|
1997-02-12 |
1998-08-13 |
Eugene Y. Chan |
Methods and products for analyzing polymers
|
US6524795B1
(en)
|
1997-03-10 |
2003-02-25 |
Interleukin Genetics, Inc. |
Diagnostics for cardiovascular disorders
|
DE19710166C1
(de)
*
|
1997-03-12 |
1998-12-10 |
Bruker Franzen Analytik Gmbh |
Zwei-Schritt-Verfahren der DNA-Amplifikation für MALDI-TOF-Messungen
|
CA2284612A1
(en)
*
|
1997-04-04 |
1998-10-15 |
Michael Knapp |
Closed-loop biochemical analyzers
|
US6235471B1
(en)
|
1997-04-04 |
2001-05-22 |
Caliper Technologies Corp. |
Closed-loop biochemical analyzers
|
US6391622B1
(en)
*
|
1997-04-04 |
2002-05-21 |
Caliper Technologies Corp. |
Closed-loop biochemical analyzers
|
ES2285768T5
(es)
|
1997-04-16 |
2011-12-22 |
Millennium Pharmaceuticals, Inc. |
Proteínas crsp (proteínas segregadas ricas en cisteína), moléculas de ácido nucleico que codifican para las mismas y uso.
|
US6451616B1
(en)
|
1997-05-19 |
2002-09-17 |
Robert W. Odom |
Analysis of molecules bound to solid surfaces using selective bond cleavage processes
|
GB9710582D0
(en)
|
1997-05-22 |
1997-07-16 |
Oxford Glycosciences Uk Ltd |
A method for de novo peptide sequence determination
|
US6426411B1
(en)
|
1997-05-30 |
2002-07-30 |
Dana-Farber Cancer Institute |
PGC-1, a novel brown fat pparγ coactivator
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
EP0991930B1
(de)
*
|
1997-06-26 |
2004-06-16 |
Perseptive Biosystems, Inc. |
Probenträger hoher dichte für die analyse biologischer proben
|
WO1999002728A1
(en)
*
|
1997-07-11 |
1999-01-21 |
Brax Group Limited |
Characterising nucleic acids
|
CA2265551A1
(en)
*
|
1997-07-11 |
1999-01-21 |
Wako Pure Chemical Industries Ltd. |
Compounds having energy transfer function and method for dna base sequencing by using the same
|
EP0994968A1
(de)
*
|
1997-07-11 |
2000-04-26 |
Brax Group Limited |
Charakterisierung von nukleinsäuren
|
NZ501774A
(en)
*
|
1997-07-22 |
2002-02-01 |
Qiagen Genomics Inc |
Computer method and system for correlating known characteristics of biomolecules to molecular tags with unique molecular weights that are associated with the biomolecule
|
CN1265156A
(zh)
*
|
1997-07-22 |
2000-08-30 |
拉普吉恩公司 |
核酸阵列上进行的扩增及其它酶反应
|
WO1999005319A2
(en)
*
|
1997-07-22 |
1999-02-04 |
Rapigene, Inc. |
Methods and compounds for analyzing nucleic acids by mass spectrometry
|
US6207370B1
(en)
|
1997-09-02 |
2001-03-27 |
Sequenom, Inc. |
Diagnostics based on mass spectrometric detection of translated target polypeptides
|
GB9718921D0
(en)
|
1997-09-05 |
1997-11-12 |
Brax Genomics Ltd |
Catalytically generated mass labels
|
US20110166040A1
(en)
*
|
1997-09-05 |
2011-07-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of e. coli o157:h7
|
CA2303790A1
(en)
*
|
1997-09-15 |
1999-03-25 |
Brax Group Limited |
Characterising nucleic acid by mass spectrometry
|
US6764822B1
(en)
|
1997-09-19 |
2004-07-20 |
Sequenom, Inc. |
DNA typing by mass spectrometry with polymorphic DNA repeat markers
|
AU9400398A
(en)
*
|
1997-09-19 |
1999-04-05 |
Genetrace Systems, Inc. |
Dna typing by mass spectrometry with polymorphic dna repeat markers
|
US6962778B1
(en)
|
1997-09-25 |
2005-11-08 |
Boston Probes, Inc. |
Methods, kits and compositions for suppressing the binding of detectable probes to non-target sequences in hybridization assays
|
US6617438B1
(en)
|
1997-11-05 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Oligoribonucleotides with enzymatic activity
|
US6127535A
(en)
*
|
1997-11-05 |
2000-10-03 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
FR2771422B1
(fr)
*
|
1997-11-21 |
2001-07-27 |
Centre Nat Rech Scient |
Reactifs et methodes pour la detection de genes lies au complexe majeur d'histocompatibilite d'oiseaux d'elevage, tels que le poulet
|
US6322968B1
(en)
|
1997-11-21 |
2001-11-27 |
Orchid Biosciences, Inc. |
De novo or “universal” sequencing array
|
US6268131B1
(en)
|
1997-12-15 |
2001-07-31 |
Sequenom, Inc. |
Mass spectrometric methods for sequencing nucleic acids
|
US6562567B2
(en)
|
1998-01-27 |
2003-05-13 |
California Institute Of Technology |
Method of detecting a nucleic acid
|
US6407816B1
(en)
*
|
1998-02-23 |
2002-06-18 |
Zygo Corporation |
Interferometer and method for measuring the refractive index and optical path length effects of air
|
US20020090639A1
(en)
*
|
1998-02-26 |
2002-07-11 |
Mcginnis Ralph Evan |
Two dimensional linkage study methods and related inventions
|
AU3463699A
(en)
*
|
1998-04-03 |
1999-10-25 |
Phylos, Inc. |
Addressable protein arrays
|
US6733967B1
(en)
|
1998-04-21 |
2004-05-11 |
Interleukin Genetics, Inc. |
Fetal testing for prediction of low birth weight
|
US7094943B2
(en)
|
1998-04-27 |
2006-08-22 |
Hubert Köster |
Solution phase biopolymer synthesis
|
US6723564B2
(en)
|
1998-05-07 |
2004-04-20 |
Sequenom, Inc. |
IR MALDI mass spectrometry of nucleic acids using liquid matrices
|
DE19822287C2
(de)
|
1998-05-18 |
2003-04-24 |
Switch Biotech Ag |
Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster
|
WO1999061910A1
(en)
*
|
1998-05-26 |
1999-12-02 |
Board Of Trustees Of The University Of Illinois |
Screening of compounds using ultrafiltration and mass spectometry
|
DE19824280B4
(de)
*
|
1998-05-29 |
2004-08-19 |
Bruker Daltonik Gmbh |
Mutationsanalyse mittels Massenspektrometrie
|
US6104028A
(en)
|
1998-05-29 |
2000-08-15 |
Genetrace Systems Inc. |
Volatile matrices for matrix-assisted laser desorption/ionization mass spectrometry
|
US6872521B1
(en)
|
1998-06-16 |
2005-03-29 |
Beckman Coulter, Inc. |
Polymerase signaling assay
|
EP0966022B1
(de)
|
1998-06-18 |
2007-05-30 |
Micromass UK Limited |
Mehrfachprobeninlassmassenspektrometer
|
US6218118B1
(en)
|
1998-07-09 |
2001-04-17 |
Agilent Technologies, Inc. |
Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry
|
US6270976B1
(en)
*
|
1998-09-15 |
2001-08-07 |
Brax Group Limited |
Characterizing nucleic acid by mass spectrometry
|
AU9505798A
(en)
*
|
1998-09-24 |
2000-04-10 |
Biotraces, Inc. |
Sequencing duplex dna by mass spectroscopy
|
US6500650B1
(en)
|
1998-10-01 |
2002-12-31 |
Variagenics, Inc. |
Method for identifying polymorphisms
|
US6777188B2
(en)
|
1998-10-01 |
2004-08-17 |
Variagenics, Inc. |
Genotyping by mass spectrometric analysis of allelic fragments
|
US6458945B1
(en)
|
1998-10-01 |
2002-10-01 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6566059B1
(en)
|
1998-10-01 |
2003-05-20 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6855500B2
(en)
|
1998-10-01 |
2005-02-15 |
Sequenom, Inc. |
Fluorescence-based genotyping
|
US6440705B1
(en)
|
1998-10-01 |
2002-08-27 |
Vincent P. Stanton, Jr. |
Method for analyzing polynucleotides
|
US6610492B1
(en)
|
1998-10-01 |
2003-08-26 |
Variagenics, Inc. |
Base-modified nucleotides and cleavage of polynucleotides incorporating them
|
US6994998B1
(en)
|
1998-10-01 |
2006-02-07 |
Sequenom, Inc. |
Base-modified nucleotides and their use for polymorphism detection
|
DE19852167C2
(de)
*
|
1998-11-12 |
2000-12-14 |
Bruker Saxonia Analytik Gmbh |
Einfache SNP-Analyse mittels Massenspektrometrie
|
DE19905082C1
(de)
*
|
1999-01-29 |
2000-05-18 |
Epigenomics Gmbh |
Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischen DNA-Proben
|
ES2353728T3
(es)
|
1999-02-10 |
2011-03-04 |
Curis, Inc. |
Péptido yy (pyy) para tratar trastornos metabólicos de la glucosa.
|
US7745216B2
(en)
|
1999-02-10 |
2010-06-29 |
Curis, Inc. |
Methods and reagents for treating glucose metabolic disorders
|
CA2361384A1
(en)
|
1999-02-11 |
2000-08-17 |
Sun Ai Raillard |
High throughput mass spectrometry
|
EP1179000A4
(de)
|
1999-02-26 |
2005-10-12 |
Millennium Pharm Inc |
Ausscheidungsproteine und ihre verwendung
|
US6225061B1
(en)
|
1999-03-10 |
2001-05-01 |
Sequenom, Inc. |
Systems and methods for performing reactions in an unsealed environment
|
US6858439B1
(en)
|
1999-03-15 |
2005-02-22 |
Aviva Biosciences |
Compositions and methods for separation of moieties on chips
|
TW496775B
(en)
|
1999-03-15 |
2002-08-01 |
Aviva Bioscience Corp |
Individually addressable micro-electromagnetic unit array chips
|
CN1185492C
(zh)
|
1999-03-15 |
2005-01-19 |
清华大学 |
可单点选通式微电磁单元阵列芯片、电磁生物芯片及应用
|
US6436640B1
(en)
|
1999-03-18 |
2002-08-20 |
Exiqon A/S |
Use of LNA in mass spectrometry
|
US20020009394A1
(en)
|
1999-04-02 |
2002-01-24 |
Hubert Koster |
Automated process line
|
US6994969B1
(en)
|
1999-04-30 |
2006-02-07 |
Methexis Genomics, N.V. |
Diagnostic sequencing by a combination of specific cleavage and mass spectrometry
|
US7056661B2
(en)
*
|
1999-05-19 |
2006-06-06 |
Cornell Research Foundation, Inc. |
Method for sequencing nucleic acid molecules
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
WO2000077812A2
(en)
*
|
1999-06-10 |
2000-12-21 |
Northeastern University |
Light-induced electron capture at a surface
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
EP1194590A2
(de)
|
1999-06-30 |
2002-04-10 |
Interleukin Genetics, Inc. |
Diagnostika und therapeutika für krankheiten assoziiert mit einem il-1 inflammatorischen haplotyp
|
US6573049B1
(en)
|
1999-07-26 |
2003-06-03 |
Nuvelo, Inc. |
Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
|
PL354286A1
(en)
|
1999-08-23 |
2003-12-29 |
Dana-Farber Cancer Institutedana-Farber Cancer Institute |
Pd-1, a receptor for b7-4, and uses therefor
|
US7723028B2
(en)
|
2000-08-30 |
2010-05-25 |
Interleukin Genetics, Inc. |
Diagnostics and therapeutics for osteoporosis
|
US6982146B1
(en)
*
|
1999-08-30 |
2006-01-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
High speed parallel molecular nucleic acid sequencing
|
CA2386791A1
(en)
|
1999-10-08 |
2001-04-19 |
Protogene Laboratories, Inc. |
Method and apparatus for performing large numbers of reactions using array assembly
|
US7917301B1
(en)
|
2000-09-19 |
2011-03-29 |
Sequenom, Inc. |
Method and device for identifying a biological sample
|
KR20020064298A
(ko)
|
1999-10-13 |
2002-08-07 |
시쿼넘, 인코포레이티드 |
다형성 유전 마커를 동정하기 위한 데이타베이스 및 이의제조 방법
|
US20030207297A1
(en)
*
|
1999-10-13 |
2003-11-06 |
Hubert Koster |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7332275B2
(en)
*
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
AU3793701A
(en)
*
|
1999-11-29 |
2001-06-04 |
Orchid Biosciences, Inc. |
Methods of identifying optimal drug combinations and compositions thereof
|
AU745917C
(en)
*
|
1999-12-08 |
2007-03-29 |
Agouron Pharmaceuticals, Inc. |
High-throughput screening of compounds using electrospray ionization mass spectrometry
|
US20030022318A1
(en)
*
|
2000-01-25 |
2003-01-30 |
Epiclone, Inc. |
Method for thermocycling amplification of nucleic acid sequences and the generation of related peptides thereof
|
CA2398107C
(en)
|
2000-01-28 |
2013-11-19 |
Althea Technologies, Inc. |
Methods for analysis of gene expression
|
KR100748297B1
(ko)
|
2000-02-29 |
2007-08-09 |
알콘, 인코퍼레이티드 |
녹내장의 진단법 및 치료법
|
US6686461B1
(en)
|
2000-03-22 |
2004-02-03 |
Solulink Bioscience, Inc. |
Triphosphate oligonucleotide modification reagents and uses thereof
|
US7102024B1
(en)
|
2000-08-01 |
2006-09-05 |
Schwartz David A |
Functional biopolymer modification reagents and uses thereof
|
AU2001253462A1
(en)
*
|
2000-04-13 |
2001-11-12 |
Thermo Finnigan, Llc |
Proteomic analysis by parallel mass spectrometry
|
DK2026073T3
(en)
|
2000-04-29 |
2016-07-25 |
Univ Iowa Res Found |
Diagnosis and treatment of macular degeneration-related disorders
|
US6475736B1
(en)
*
|
2000-05-23 |
2002-11-05 |
Variagenics, Inc. |
Methods for genetic analysis of DNA using biased amplification of polymorphic sites
|
US6660229B2
(en)
|
2000-06-13 |
2003-12-09 |
The Trustees Of Boston University |
Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
|
DE60131194T2
(de)
*
|
2000-07-07 |
2008-08-07 |
Visigen Biotechnologies, Inc., Bellaire |
Sequenzbestimmung in echtzeit
|
US6958214B2
(en)
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
AU2001271998A1
(en)
*
|
2000-07-13 |
2002-01-30 |
The Johns Hopkins University School Of Medicine |
Detection and treatment of polycystic kidney disease
|
EP1191036A3
(de)
|
2000-08-25 |
2002-07-03 |
Pfizer Products Inc. |
Methoden und Verbindungen zur Diagnose und Behandlung von Krankheiten, an denen Angiogenese beteiligt ist
|
GB0021286D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Gemini Genomics Ab |
Identification of drug metabolic capacity
|
US6747142B1
(en)
|
2000-09-05 |
2004-06-08 |
Fidelity Systems, Inc. |
Multiple methoxyoxalamido and succinimido precursors for nucleophilic addition
|
US6548251B1
(en)
|
2000-09-05 |
2003-04-15 |
Fidelity Systems, Inc. |
Inhibition of molecular and biological processes using modified oligonucleotides
|
US6963807B2
(en)
|
2000-09-08 |
2005-11-08 |
Oxford Glycosciences (Uk) Ltd. |
Automated identification of peptides
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
WO2002066952A2
(en)
|
2000-10-19 |
2002-08-29 |
Target Discovery, Inc |
Mass defect labeling for the determination of oligomer sequences
|
US6479242B1
(en)
|
2000-10-26 |
2002-11-12 |
Cleveland State University |
Method for genotyping of single nucleotide polymorphism
|
EP1332000B1
(de)
|
2000-10-30 |
2012-06-20 |
Sequenom, Inc. |
Verfahren zur aufbringung von submikroliter fluid-volumina auf ein substrat
|
BR0115715A
(pt)
|
2000-11-28 |
2004-02-03 |
Wyeth Corp |
Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
|
BR0115728A
(pt)
|
2000-11-28 |
2003-09-23 |
Wyeth Corp |
Análise da expressão de ácidos nucléicos kiaa e polipeptìdeos úteis no diagnóstico e tratamento de cáncer de próstata
|
WO2002044425A2
(en)
|
2000-12-01 |
2002-06-06 |
Visigen Biotechnologies, Inc. |
Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
|
EP2341060B1
(de)
|
2000-12-12 |
2019-02-20 |
MedImmune, LLC |
Moleküle mit längeren Halbwertszeiten, Zusammensetzungen und deren Verwendung
|
DE60140693D1
(en)
|
2000-12-14 |
2010-01-14 |
Amylin Pharmaceuticals Inc |
Ankheiten
|
US20030232332A1
(en)
*
|
2000-12-18 |
2003-12-18 |
Muralidhara Padigaru |
Novel proteins and nucleic acids encoding same
|
WO2002052045A1
(en)
*
|
2000-12-26 |
2002-07-04 |
Aviva Biosciences |
Active and biocompatible platforms prepared by polymerization of surface coating films
|
FI115139B
(fi)
*
|
2001-01-10 |
2005-03-15 |
Valtion Teknillinen |
Menetelmä ja testipakkaus solu- tai kudosnäytteissä olevien polynukleotidien määrässä tapahtuvien vaihteluiden kvantitatiiviseen ja/tai vertailevaan arvioimiseen
|
DE10108453B4
(de)
*
|
2001-02-22 |
2005-10-20 |
Bruker Daltonik Gmbh |
Massenspektrometrische Mutationsanalyse mit photolytisch spaltbaren Primern
|
ATE305521T1
(de)
*
|
2001-02-27 |
2005-10-15 |
Deutsches Krebsforsch |
Verfahren zur bindung von nukleinsäuren an einen träger
|
US20040121335A1
(en)
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
|
US20030027135A1
(en)
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
US7226739B2
(en)
*
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
US7666588B2
(en)
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
US20040121314A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in containers
|
US7718354B2
(en)
*
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20040121310A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in forensic studies
|
IL158000A0
(en)
*
|
2001-03-19 |
2004-03-28 |
Harvard College |
Evolving new molecular function
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
EP2388590A1
(de)
|
2001-04-02 |
2011-11-23 |
Dana Farber Cancer Institute |
PD-1, ein Rezeptor für B7-4, und Verwendungen dafür
|
EP2278013A1
(de)
|
2001-04-16 |
2011-01-26 |
Wyeth Holdings Corporation |
Polypeptidantigene codierende offene Leseraster aus Streptococcus Pneumoniae und Verwendungen davon
|
US20020155587A1
(en)
|
2001-04-20 |
2002-10-24 |
Sequenom, Inc. |
System and method for testing a biological sample
|
GB0111324D0
(en)
|
2001-05-09 |
2001-07-04 |
Unilever Plc |
Ambient stable beverage
|
WO2002102820A1
(en)
*
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
US8073627B2
(en)
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
US7668697B2
(en)
*
|
2006-02-06 |
2010-02-23 |
Andrei Volkov |
Method for analyzing dynamic detectable events at the single molecule level
|
WO2003006677A2
(en)
|
2001-07-12 |
2003-01-23 |
Illumina, Inc. |
Multiplex nucleic acid reactions
|
EP2053406A3
(de)
|
2001-07-16 |
2009-06-24 |
caprotec bioanalytics GmbH |
Capture Compounds, Sammlung derselben und Verfahren zur Proteomanalyse und Komplexzusammensetzung
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
WO2003054143A2
(en)
*
|
2001-10-25 |
2003-07-03 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
CA2464682A1
(en)
|
2001-10-26 |
2003-05-01 |
Sequenom, Inc. |
Method and apparatus for high-throughput sample handling process line
|
WO2003051174A2
(en)
*
|
2001-11-09 |
2003-06-26 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20050054113A1
(en)
*
|
2001-12-31 |
2005-03-10 |
William Bedingham |
Methods of processing sample processing devices
|
AU2003201159A1
(en)
|
2002-01-08 |
2003-07-24 |
Bayer Healthcare Ag |
Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
|
US20040209255A1
(en)
*
|
2002-03-11 |
2004-10-21 |
Hk Pharmaceuticals, Inc. |
Compounds and methods for analyzing the proteome
|
US20050164193A1
(en)
*
|
2002-03-25 |
2005-07-28 |
Epigenomics Ag |
Method for the analysis of methylation patterns within nucleic acids by means of mass spectrometry
|
US6723546B2
(en)
*
|
2002-03-26 |
2004-04-20 |
New England Biolabs, Inc. |
Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli
|
WO2003083130A2
(en)
|
2002-03-28 |
2003-10-09 |
The Johns Hopkins University |
Detection of malaria parasites by mass spectrometry
|
WO2003100035A2
(en)
*
|
2002-04-01 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Method for rapid detection and identification of viral bioagents
|
US7432342B2
(en)
|
2002-05-03 |
2008-10-07 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof and related documents
|
US20030220844A1
(en)
*
|
2002-05-24 |
2003-11-27 |
Marnellos Georgios E. |
Method and system for purchasing genetic data
|
US6906163B2
(en)
*
|
2002-05-30 |
2005-06-14 |
Bayer Materialscience Llc |
Prepolymer catalysts suitable for preparing spandex fibers
|
WO2003101177A2
(en)
*
|
2002-06-04 |
2003-12-11 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
|
US20050239077A1
(en)
*
|
2002-06-27 |
2005-10-27 |
Adam Gail I R |
Diagnosing predisposition to fat deposition and associated conditions
|
EP1581095A4
(de)
*
|
2002-06-27 |
2006-10-18 |
Harkness Pharmaceuticals Inc |
Therapeutische methoden zur reduzierung der fettablagerung und zur behandlung von damit einhergehenden erkrankungen
|
US20040137491A1
(en)
*
|
2002-06-28 |
2004-07-15 |
Tadashi Okamoto |
Method of analyzing probe carrier using time-of-flight secondary ion mass spectrometry
|
WO2004011625A2
(en)
|
2002-07-31 |
2004-02-05 |
University Of Southern California |
Polymorphisms for predicting disease and treatment outcome
|
WO2004016767A2
(en)
*
|
2002-08-19 |
2004-02-26 |
The President And Fellows Of Harvard College |
Evolving new molecular function
|
AU2003272361A1
(en)
*
|
2002-09-11 |
2005-04-11 |
Sequenom, Inc. |
Methods for identifying subjects at risk of melanoma and treatments thereof
|
WO2004044163A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Sequenom, Inc. |
Methods for identifying risk of melanoma and treatments thereof
|
ATE426043T1
(de)
*
|
2002-11-25 |
2009-04-15 |
Sequenom Inc |
Verfahren zur identifizierung des brustkrebsrisikos
|
WO2004048548A2
(en)
*
|
2002-11-25 |
2004-06-10 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US20050064442A1
(en)
*
|
2002-11-25 |
2005-03-24 |
Roth Richard B. |
Methods for identifying risk of breast cancer and treatments thereof
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
CA2507189C
(en)
|
2002-11-27 |
2018-06-12 |
Sequenom, Inc. |
Fragmentation-based methods and systems for sequence variation detection and discovery
|
CA2508726A1
(en)
|
2002-12-06 |
2004-07-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20040115655A1
(en)
*
|
2002-12-16 |
2004-06-17 |
Ilsley Diane D. |
Method for analyzing the nucleotide sequence of nucleic acids
|
US20040121315A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in containers thereby
|
US20040122857A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in forensic studies thereby
|
US20040121312A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of the absence of bioagents
|
JP5479663B2
(ja)
|
2002-12-20 |
2014-04-23 |
セレラ コーポレーション |
心筋梗塞に関連する遺伝的多型、その検出方法および使用
|
EP2368578A1
(de)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identifizierung und Herstellung von Antikörpern mit abweichenden FC-Regionen und Anwendungsverfahren dafür
|
EP2272533A1
(de)
|
2003-01-13 |
2011-01-12 |
MacroGenics, Inc. |
Lösliche FcyR-Fusionsproteine und Verfahren zu deren Verwendung
|
CA2658334C
(en)
*
|
2003-01-16 |
2012-07-10 |
Caprotec Bioanalytics Gmbh |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US20090186343A1
(en)
*
|
2003-01-28 |
2009-07-23 |
Visigen Biotechnologies, Inc. |
Methods for preparing modified biomolecules, modified biomolecules and methods for using same
|
US20040157220A1
(en)
|
2003-02-10 |
2004-08-12 |
Purnima Kurnool |
Methods and apparatus for sample tracking
|
US20070141570A1
(en)
*
|
2003-03-07 |
2007-06-21 |
Sequenom, Inc. |
Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
|
US8507285B2
(en)
*
|
2003-03-13 |
2013-08-13 |
Agilent Technologies, Inc. |
Methods and devices for identifying biopolymers using mass spectroscopy
|
US8017323B2
(en)
*
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
US8046171B2
(en)
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
AU2004235331B2
(en)
*
|
2003-04-25 |
2008-12-18 |
Sequenom, Inc. |
Fragmentation-based methods and systems for De Novo sequencing
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US7964343B2
(en)
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US20040248104A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Zohar Yakhini |
Methods and reagents for profiling quantities of nucleic acids
|
US7947817B2
(en)
|
2003-06-30 |
2011-05-24 |
Roche Molecular Systems, Inc. |
Synthesis and compositions of 2'-terminator nucleotides
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
US20050233341A1
(en)
*
|
2003-07-23 |
2005-10-20 |
Roth Richard R |
Methods for identifying risk of melanoma and treatments thereof
|
US20050272043A1
(en)
*
|
2003-07-24 |
2005-12-08 |
Roth Richard B |
Methods for identifying risk of breast cancer and treatments thereof
|
US8003317B2
(en)
|
2003-07-31 |
2011-08-23 |
Sequenom, Inc. |
Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions
|
US20050123952A1
(en)
*
|
2003-09-04 |
2005-06-09 |
Griffey Richard H. |
Methods of rapid detection and identification of bioagents using microRNA
|
WO2005024068A2
(en)
|
2003-09-05 |
2005-03-17 |
Sequenom, Inc. |
Allele-specific sequence variation analysis
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US20120122099A1
(en)
|
2003-09-11 |
2012-05-17 |
Rangarajan Sampath |
Compositions for use in identification of bacteria
|
US20100129811A1
(en)
*
|
2003-09-11 |
2010-05-27 |
Ibis Biosciences, Inc. |
Compositions for use in identification of pseudomonas aeruginosa
|
US20100035239A1
(en)
*
|
2003-09-11 |
2010-02-11 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of bacteria
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
ES2453895T3
(es)
|
2003-09-23 |
2014-04-08 |
University Of North Carolina At Chapel Hill |
Células que expresan vitamina K epóxido reductasa y uso de las mismas
|
US20050142584A1
(en)
*
|
2003-10-01 |
2005-06-30 |
Willson Richard C. |
Microbial identification based on the overall composition of characteristic oligonucleotides
|
WO2005042709A2
(en)
*
|
2003-10-29 |
2005-05-12 |
Ribomed Biotechnologies, Inc. |
Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
|
JP5649263B2
(ja)
|
2003-11-26 |
2015-01-07 |
セレラ コーポレーション |
心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
|
US8163895B2
(en)
|
2003-12-05 |
2012-04-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of orthopoxviruses
|
US7662389B2
(en)
|
2003-12-17 |
2010-02-16 |
Alcon, Inc. |
Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
|
US20100113481A1
(en)
|
2003-12-17 |
2010-05-06 |
Alcon Research, Ltd. |
Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
|
TWI398261B
(zh)
|
2003-12-17 |
2013-06-11 |
Alcon Inc |
血清類澱粉a基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途
|
JP2007517511A
(ja)
*
|
2004-01-10 |
2007-07-05 |
バイエル・ヘルスケア・エルエルシー |
ヒトチオプリンs−メチルトランスフェラーゼ欠損に関連するハプロタイプおよび多型
|
WO2005073409A2
(en)
*
|
2004-01-26 |
2005-08-11 |
Applera Corporation |
Methods, compositions, and kits for amplifying and sequencing polynucleotides
|
US8603969B2
(en)
|
2004-02-11 |
2013-12-10 |
Amylin Pharmaceuticals, Llc |
Pancreatic polypeptide family motifs and polypeptides comprising the same
|
US7666592B2
(en)
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
US7608394B2
(en)
|
2004-03-26 |
2009-10-27 |
Sequenom, Inc. |
Methods and compositions for phenotype identification based on nucleic acid methylation
|
CA2561381C
(en)
|
2004-03-26 |
2015-05-12 |
Sequenom, Inc. |
Base specific cleavage of methylation-specific amplification products in combination with mass analysis
|
EP2423327B1
(de)
|
2004-05-07 |
2014-01-08 |
Celera Corporation |
Genetischer Polymorphismus und Leberfibrose, Verfahren zur Erkennung und Verwendung davon
|
EP1756307A1
(de)
*
|
2004-05-20 |
2007-02-28 |
Trillion Genomics Limited |
Verwendung massenmarkierter sonden zum nachweis von zielnukleinsäuren mittels massenspektrometrie
|
US7459548B2
(en)
*
|
2004-05-21 |
2008-12-02 |
Mo Bio Laboratories, Inc. |
Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
|
CA2567839C
(en)
|
2004-05-24 |
2011-06-28 |
Isis Pharmaceuticals, Inc. |
Mass spectrometry with selective ion filtration by digital thresholding
|
US20050266411A1
(en)
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
WO2005118856A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US7745125B2
(en)
*
|
2004-06-28 |
2010-06-29 |
Roche Molecular Systems, Inc. |
2′-terminator related pyrophosphorolysis activated polymerization
|
US7928207B2
(en)
*
|
2004-06-28 |
2011-04-19 |
Roche Molecular Systems, Inc |
Synthesis and compositions of nucleic acids comprising 2′-terminator nucleotides
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
EP1773860A4
(de)
*
|
2004-07-22 |
2009-05-06 |
Sequenom Inc |
Verfahren zur identifizierung des risikos von typ-ii-diabetes und zur behandlung davon
|
WO2006031745A2
(en)
*
|
2004-09-10 |
2006-03-23 |
Sequenom, Inc. |
Methods for long-range sequence analysis of nucleic acids
|
GB2423819B
(en)
*
|
2004-09-17 |
2008-02-06 |
Pacific Biosciences California |
Apparatus and method for analysis of molecules
|
US7170050B2
(en)
|
2004-09-17 |
2007-01-30 |
Pacific Biosciences Of California, Inc. |
Apparatus and methods for optical analysis of molecules
|
US7445896B2
(en)
*
|
2004-10-18 |
2008-11-04 |
University Of Washington |
Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
|
EP1809765A2
(de)
*
|
2004-11-04 |
2007-07-25 |
Roche Diagnostics GmbH |
Klassifizierung von aml (akuter myeloider leukämie)
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
WO2006081426A2
(en)
*
|
2005-01-28 |
2006-08-03 |
Applera Corporation |
Compositions and methods for terminating a sequencing reaction at a specific location in a target dna template
|
US8084207B2
(en)
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
CA2600184A1
(en)
|
2005-03-03 |
2006-09-08 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of adventitious viruses
|
CA2600794C
(en)
|
2005-03-11 |
2014-08-12 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
AU2005329450A1
(en)
|
2005-03-15 |
2006-09-28 |
University Of North Carolina At Chapel Hill |
Methods and compositions for producing active Vitamin K-dependent proteins
|
ES2261072B1
(es)
*
|
2005-04-06 |
2007-12-16 |
Consejo Superior Investig. Cientificas |
Fosforotioatos derivados de analogos a nucleosido para terapia antirretroviral.
|
EP1874811B1
(de)
|
2005-04-15 |
2012-06-13 |
President and Fellows of Harvard College |
Verfahren zur Modulation der Knochenbildung und -mineralisation durch Modulation der KRC-Aktivität
|
US8026084B2
(en)
|
2005-07-21 |
2011-09-27 |
Ibis Biosciences, Inc. |
Methods for rapid identification and quantitation of nucleic acid variants
|
DK1919503T3
(en)
|
2005-08-10 |
2014-12-15 |
Macrogenics Inc |
Identification and preparation of antibodies with variant fc regions and methods of use thereof
|
EP1937838B1
(de)
|
2005-09-22 |
2011-03-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur verwendung von il-21
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
EP1951903A2
(de)
|
2005-10-25 |
2008-08-06 |
Interleukin Genetics, Inc. |
Der il-1-gencluster und damit assoziierte entzündungspolymorphismen und haplotypen
|
WO2007053732A2
(en)
|
2005-11-01 |
2007-05-10 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the blys gene and use in diagnostic methods
|
AU2006337105B2
(en)
|
2005-11-01 |
2013-05-02 |
Abbvie Biotechnology Ltd |
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
|
US8344121B2
(en)
*
|
2005-12-12 |
2013-01-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Nanoprobes for detection or modification of molecules
|
US8703734B2
(en)
|
2005-12-12 |
2014-04-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoprobes for detection or modification of molecules
|
WO2007112289A2
(en)
*
|
2006-03-23 |
2007-10-04 |
The Regents Of The University Of California |
Method for identification and sequencing of proteins
|
EP2010679A2
(de)
|
2006-04-06 |
2009-01-07 |
Ibis Biosciences, Inc. |
Zusammensetzungen für die identifizierung von pilzen
|
AU2007244683A1
(en)
|
2006-04-27 |
2007-11-08 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
US20100285973A1
(en)
*
|
2006-05-30 |
2010-11-11 |
Synergenz Bioscience Limited of Sea Meadow House |
Methods and compositions for assessment of pulmonary function and disorders
|
EP2029777B1
(de)
|
2006-05-31 |
2017-03-08 |
Sequenom, Inc. |
Verfahren und zusammensetzungen zur nukleinsäureextraktion aus einer probe
|
EP2035439A4
(de)
|
2006-06-05 |
2010-01-13 |
Cancer Care Ontario |
Abschätzung des risikos von colorectalkrebs
|
US7772390B1
(en)
|
2006-07-18 |
2010-08-10 |
The Regents Of The University Of California |
Lipid mediated nucleic acid synthesis
|
US20080241938A1
(en)
*
|
2006-07-20 |
2008-10-02 |
Visigen Biotechnologies, Inc. |
Automated synthesis or sequencing apparatus and method for making and using same
|
US20080091005A1
(en)
*
|
2006-07-20 |
2008-04-17 |
Visigen Biotechnologies, Inc. |
Modified nucleotides, methods for making and using same
|
US20080241951A1
(en)
*
|
2006-07-20 |
2008-10-02 |
Visigen Biotechnologies, Inc. |
Method and apparatus for moving stage detection of single molecular events
|
US9582639B2
(en)
|
2006-08-11 |
2017-02-28 |
University Of Tennessee Research Foundation |
Method and apparatus for mobile disaster victim identification
|
JP5420412B2
(ja)
|
2006-09-14 |
2014-02-19 |
アイビス バイオサイエンシズ インコーポレイティッド |
病原体の同定のための標的全ゲノム増幅方法
|
EP2064335A4
(de)
|
2006-10-16 |
2011-03-30 |
Medimmune Llc |
Moleküle mit reduzierter halbwertzeit, zusammensetzungen und ihre verwendung
|
CA2915679C
(en)
|
2006-10-20 |
2017-12-12 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
US20080145898A1
(en)
*
|
2006-12-14 |
2008-06-19 |
Applera Corporation |
Sequencing methods
|
EP2126117A2
(de)
*
|
2007-01-18 |
2009-12-02 |
University Of Southern California |
Für duale tki-therapie prädiktive genpoylmorphismen
|
US8076104B2
(en)
*
|
2007-01-25 |
2011-12-13 |
Rogan Peter K |
Rapid and comprehensive identification of prokaryotic organisms
|
WO2008098142A2
(en)
|
2007-02-08 |
2008-08-14 |
Sequenom, Inc. |
Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
|
JP5680304B2
(ja)
|
2007-02-23 |
2015-03-04 |
アイビス バイオサイエンシズ インコーポレイティッド |
迅速な法医学的dna分析法
|
AU2008222563A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US8652780B2
(en)
|
2007-03-26 |
2014-02-18 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US20080241831A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Jian-Bing Fan |
Methods for detecting small RNA species
|
US7811766B2
(en)
*
|
2007-03-28 |
2010-10-12 |
Thinkvillage, Llc |
Genetic identification and validation of Echinacea species
|
US20090006002A1
(en)
*
|
2007-04-13 |
2009-01-01 |
Sequenom, Inc. |
Comparative sequence analysis processes and systems
|
US8527207B2
(en)
*
|
2007-05-15 |
2013-09-03 |
Peter K. Rogan |
Accurate identification of organisms based on individual information content
|
WO2009023358A2
(en)
*
|
2007-05-25 |
2009-02-19 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of hepatitis c virus
|
AU2008260029B2
(en)
|
2007-05-31 |
2015-02-12 |
Yale University |
A genetic lesion associated with cancer
|
WO2008151023A2
(en)
|
2007-06-01 |
2008-12-11 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
JP5494480B2
(ja)
|
2007-06-11 |
2014-05-14 |
和光純薬工業株式会社 |
集積リアルタイムce検出を用いるマイクロチップ大容量pcr
|
US20110045456A1
(en)
*
|
2007-06-14 |
2011-02-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious contaminant viruses
|
WO2009032781A2
(en)
|
2007-08-29 |
2009-03-12 |
Sequenom, Inc. |
Methods and compositions for universal size-specific polymerase chain reaction
|
JP5963341B2
(ja)
|
2007-09-14 |
2016-08-10 |
アムジエン・インコーポレーテツド |
均質な抗体集団
|
US20090180931A1
(en)
|
2007-09-17 |
2009-07-16 |
Sequenom, Inc. |
Integrated robotic sample transfer device
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
US7892760B2
(en)
|
2007-11-19 |
2011-02-22 |
Celera Corporation |
Lung cancer markers, and uses thereof
|
US8003325B2
(en)
|
2007-11-30 |
2011-08-23 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the BLyS gene and use in diagnostic methods
|
US20100273166A1
(en)
*
|
2007-12-13 |
2010-10-28 |
Nxp B.V. |
biosensor device and method of sequencing biological particles
|
EP3699291A1
(de)
|
2008-01-17 |
2020-08-26 |
Sequenom, Inc. |
Einzelmolekülnukleinsäurensequenzanalyseverfahren und zusammensetzungen
|
MX340916B
(es)
|
2008-01-18 |
2016-07-29 |
President And Fellows Of Harvard College * |
Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
|
US20110097704A1
(en)
*
|
2008-01-29 |
2011-04-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of picornaviruses
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
AU2009223671B2
(en)
|
2008-03-11 |
2014-11-27 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
CA2718137A1
(en)
|
2008-03-26 |
2009-10-01 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
BRPI0909212A2
(pt)
|
2008-03-28 |
2015-08-18 |
Pacific Biosciences California |
Composições e método para sequeciamento de ácido nucléico
|
EP3467126A1
(de)
|
2008-05-02 |
2019-04-10 |
Orig3n, Inc. |
Nachweis von genetischer veranlagung für osteoarthritische erkrankungen
|
US20100098809A1
(en)
|
2008-05-16 |
2010-04-22 |
Interleukin Genetics, Inc. |
Genetic marker weight management
|
WO2009151982A1
(en)
*
|
2008-05-30 |
2009-12-17 |
Ibis Biosciences, Inc. |
Compositions for use in identification of francisella
|
WO2009155103A2
(en)
*
|
2008-05-30 |
2009-12-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of tick-borne pathogens
|
WO2009148995A2
(en)
*
|
2008-06-02 |
2009-12-10 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious viruses
|
EP2733222A1
(de)
|
2008-07-09 |
2014-05-21 |
Celera Corporation |
Mit kardiovaskulären Krankheiten assoziierte, genetische Polymorphismen, Verfahren zum Nachweis und Verwendungen davon
|
CN102177438A
(zh)
|
2008-07-25 |
2011-09-07 |
理查德·W·瓦格纳 |
蛋白筛选方法
|
EP2344893B1
(de)
|
2008-09-16 |
2014-10-15 |
Ibis Biosciences, Inc. |
Mikroplatten-handhabungssysteme und verfahren
|
JP5727375B2
(ja)
|
2008-09-16 |
2015-06-03 |
セクエノム, インコーポレイテッド |
非侵襲性の出生前診断のために有用な、母体サンプル由来の胎児核酸のメチル化に基づく濃縮のためのプロセスおよび組成物
|
EP2347254A2
(de)
|
2008-09-16 |
2011-07-27 |
Ibis Biosciences, Inc. |
Probenverarbeitungseinheiten, -systeme und damit verbundene verfahren
|
EP2349549B1
(de)
|
2008-09-16 |
2012-07-18 |
Ibis Biosciences, Inc. |
Mischpatronen, mischstationen und verwandte ausrüstungen, und system
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US20110200985A1
(en)
*
|
2008-10-02 |
2011-08-18 |
Rangarajan Sampath |
Compositions for use in identification of herpesviruses
|
WO2010039755A1
(en)
*
|
2008-10-02 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial genus mycoplasma
|
WO2010039870A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of neisseria, chlamydia, and/or chlamydophila bacteria
|
US20110183344A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Rangarajan Sampath |
Compositions for use in identification of clostridium difficile
|
WO2010039775A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial class alphaproteobacter
|
WO2010039848A2
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of streptococcus pneumoniae
|
WO2010039763A2
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of antibiotic-resistant bacteria
|
EP2358905A1
(de)
*
|
2008-12-19 |
2011-08-24 |
Abbott Laboratories |
Diagnosetest für mutationen bei kodonen 12-13 des menschlichen k-ras
|
WO2010080616A1
(en)
|
2008-12-19 |
2010-07-15 |
Abbott Laboratories |
Molecular assay for diagnosis of malaria
|
CA2751287A1
(en)
|
2009-02-06 |
2010-09-10 |
Yale University |
A snp marker of breast and ovarian cancer risk
|
EP2394175B1
(de)
*
|
2009-02-09 |
2016-02-03 |
caprotec bioanalytics GmbH |
Vorrichtungen, systeme und verfahren zur trennung magnetischer partikel
|
JP2012517238A
(ja)
|
2009-02-11 |
2012-08-02 |
カリス エムピーアイ インコーポレイテッド |
腫瘍の分子プロファイリング法
|
US8158936B2
(en)
|
2009-02-12 |
2012-04-17 |
Ibis Biosciences, Inc. |
Ionization probe assemblies
|
WO2010104798A1
(en)
|
2009-03-08 |
2010-09-16 |
Ibis Biosciences, Inc. |
Bioagent detection methods
|
EP2408936A4
(de)
*
|
2009-03-18 |
2013-01-30 |
Sequenom Inc |
Verwendung wärmestabiler endonukleasen zur herstellung von reportermolekülen
|
US9393564B2
(en)
|
2009-03-30 |
2016-07-19 |
Ibis Biosciences, Inc. |
Bioagent detection systems, devices, and methods
|
EP3211095B1
(de)
|
2009-04-03 |
2019-01-02 |
Sequenom, Inc. |
Zusammensetzungen und verfahren für die herstellung von nukleinsäuren
|
WO2010123625A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms predict clinical outcome in patients with cancer
|
US20110171619A1
(en)
*
|
2009-05-28 |
2011-07-14 |
Daniel Leo Sweeney |
Representation of molecules as sets of masses of complementary subgroups and contiguous complementary subgroups
|
EP2261242A1
(de)
|
2009-06-10 |
2010-12-15 |
Universite Catholique De Louvain |
Aspartat-N-Acetyltransferaseenzym, Diagnoseverfahren und therapeutisches Verfahren
|
EP2446056A2
(de)
|
2009-06-25 |
2012-05-02 |
Yale University |
Einzelnukleotidpolymorphismen im brca1-gen und krebsrisiko
|
WO2011004345A1
(en)
|
2009-07-09 |
2011-01-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Upstream binding protein 1 polymorphisms and their use for prognosing or diagnosing arterial blood pressure
|
WO2011008971A1
(en)
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
WO2011008972A1
(en)
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Systems for bioagent identification
|
WO2011014811A1
(en)
|
2009-07-31 |
2011-02-03 |
Ibis Biosciences, Inc. |
Capture primers and capture sequence linked solid supports for molecular diagnostic tests
|
EP3098325A1
(de)
|
2009-08-06 |
2016-11-30 |
Ibis Biosciences, Inc. |
Basenzusammensetzungen ohne massenbestimmung zur nukleinsäureerkennung
|
US20110065111A1
(en)
*
|
2009-08-31 |
2011-03-17 |
Ibis Biosciences, Inc. |
Compositions For Use In Genotyping Of Klebsiella Pneumoniae
|
US9890408B2
(en)
|
2009-10-15 |
2018-02-13 |
Ibis Biosciences, Inc. |
Multiple displacement amplification
|
WO2011056688A2
(en)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Molecular profiling for personalized medicine
|
CA2780875A1
(en)
|
2009-11-13 |
2011-05-19 |
Pangaea Biotech, S.L. |
Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
|
EP2499159B1
(de)
|
2009-11-13 |
2017-01-04 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
WO2011084757A1
(en)
|
2009-12-21 |
2011-07-14 |
University Of Southern California |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
US9745589B2
(en)
|
2010-01-14 |
2017-08-29 |
Cornell University |
Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
|
US20120014956A1
(en)
|
2010-02-02 |
2012-01-19 |
Hartmut Kupper |
Methods and compositions for predicting responsiveness to treatment with tnf-alpha inhibitor
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US9758840B2
(en)
|
2010-03-14 |
2017-09-12 |
Ibis Biosciences, Inc. |
Parasite detection via endosymbiont detection
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
US9738938B2
(en)
|
2010-05-07 |
2017-08-22 |
Medical Diagnostic Laboratories, Llc |
Single nucleotide polymorphisms and community-associated methicillin-resistant Staphylococcus aureus
|
DK2399928T3
(da)
|
2010-06-23 |
2018-01-29 |
Deutsches Krebsforsch |
Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet
|
PT2585477T
(pt)
|
2010-06-23 |
2018-10-12 |
Deutsches Krebsforsch |
Moléculas de vírus tt reorganizadas para utilização em diagnóstico, prevenção e tratamento de cancro e autoimunidade
|
KR20130041961A
(ko)
|
2010-07-23 |
2013-04-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
체액에서 질환 또는 상태의 특징을 검출하는 방법
|
AU2011280936A1
(en)
|
2010-07-23 |
2013-02-28 |
President And Fellows Of Harvard College |
Methods of detecting prenatal or pregnancy-related diseases or conditions
|
EP2596116A4
(de)
|
2010-07-23 |
2014-03-19 |
Harvard College |
Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
|
US20120077738A1
(en)
|
2010-09-24 |
2012-03-29 |
Wisconsin Alumni Research Foundation |
Compositions and methods for predicting hcv susceptibility to antiviral agents
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
CA2816991C
(en)
|
2010-11-05 |
2020-06-09 |
Morphotek Inc. |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
WO2012088222A2
(en)
|
2010-12-21 |
2012-06-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
WO2012109238A2
(en)
|
2011-02-07 |
2012-08-16 |
President And Fellows Of Harvard College |
Methods for increasing immune responses using agents that directly bind to and activate ire-1
|
US20140024590A1
(en)
|
2011-02-18 |
2014-01-23 |
Yale University |
KRAS-Variant And Endometriosis
|
EP2492688A1
(de)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molekulare Biomarker zur Vorhersage der Reaktion auf die Antitumorbehandlung bei Lungenkrebs
|
SG10201601224WA
(en)
|
2011-03-02 |
2016-03-30 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
JP2014509515A
(ja)
|
2011-03-18 |
2014-04-21 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
エリブリンに対する応答を予測するための方法及び組成物
|
US20140065615A1
(en)
|
2011-03-21 |
2014-03-06 |
Yale University |
The KRAS Variant and Tumor Biology
|
AU2012249531B2
(en)
|
2011-04-29 |
2017-06-29 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
WO2012159089A1
(en)
|
2011-05-19 |
2012-11-22 |
Sequenom, Inc. |
Products and processes for multiplex nucleic acid identification
|
US10711308B2
(en)
|
2011-06-17 |
2020-07-14 |
Brigham And Women's Hospital, Inc. |
Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects
|
ES2704126T3
(es)
|
2011-08-23 |
2019-03-14 |
Found Medicine Inc |
Moléculas de fusión KIF5B-RET y usos de las mismas
|
WO2013043554A1
(en)
|
2011-09-23 |
2013-03-28 |
Access Business Group International Llc |
Methods for creating recommended dietary regime
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
BR112014007485B1
(pt)
|
2011-10-20 |
2022-05-31 |
Novartis Ag |
Métodos para prever responsividade terapêutica de um indivíduo a tratamento com um ativador do receptor de acetilcolina nicotínico alfa 7, e usos do referido ativador
|
CA2857597A1
(en)
|
2011-11-30 |
2013-06-06 |
AbbVie Deutschland GmbH & Co. KG |
Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
|
RS57827B1
(sr)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk As |
Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
DK2814844T3
(da)
|
2012-02-15 |
2017-11-13 |
Novo Nordisk As |
Antistoffer, der binder og blokerer udløsende receptor udtrykt på myeloide celler-1 (trem-1)
|
EP2820129A1
(de)
|
2012-03-02 |
2015-01-07 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
SG11201406201YA
(en)
|
2012-04-02 |
2014-10-30 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9730941B2
(en)
|
2012-06-07 |
2017-08-15 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the inhibition of Pin1
|
US20140004105A1
(en)
|
2012-06-29 |
2014-01-02 |
Sequenom, Inc. |
Age-related macular degeneration diagnostics
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2014015098A1
(en)
|
2012-07-18 |
2014-01-23 |
Siemens Healthcare Diagnostics Inc. |
A method of normalizing biological samples
|
CA2880764C
(en)
|
2012-08-03 |
2022-08-30 |
Foundation Medicine, Inc. |
Human papilloma virus as predictor of cancer prognosis
|
WO2014055790A2
(en)
|
2012-10-04 |
2014-04-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
EP2912194B1
(de)
|
2012-10-26 |
2019-05-08 |
Memorial Sloan-Kettering Cancer Center |
Androgenrezeptorvarianten und verfahren zur herstellung und verwendung
|
US10260089B2
(en)
|
2012-10-29 |
2019-04-16 |
The Research Foundation Of The State University Of New York |
Compositions and methods for recognition of RNA using triple helical peptide nucleic acids
|
EP2914621B1
(de)
|
2012-11-05 |
2023-06-07 |
Foundation Medicine, Inc. |
Neuartige ntrk1-fusionsmoleküle und verwendungen davon
|
JP6114951B2
(ja)
|
2012-12-11 |
2017-04-19 |
ノバルティス アーゲー |
アルファ7ニコチン性アセチルコリン受容体アクチベーターによる処置に対する応答性を予測するバイオマーカー
|
CA2898326C
(en)
|
2013-01-18 |
2022-05-17 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
WO2014164366A1
(en)
|
2013-03-09 |
2014-10-09 |
Harry Stylli |
Methods of detecting cancer
|
US11585814B2
(en)
|
2013-03-09 |
2023-02-21 |
Immunis.Ai, Inc. |
Methods of detecting prostate cancer
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
EP2805769A1
(de)
|
2013-05-24 |
2014-11-26 |
European Molecular Biology Laboratory |
Verfahren zur nanoskaligen Einzelzellenanalyse
|
US20160122829A1
(en)
|
2013-06-06 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 Isoforms
|
EP3008211A4
(de)
|
2013-06-11 |
2016-12-21 |
Courtagen Life Sciences Inc |
Verfahren und kits zur behandlung und klassifizierung von personen mit risiko einer oder bestehender trap1-funktionsänderung
|
WO2015009831A2
(en)
|
2013-07-17 |
2015-01-22 |
Foundation Medicine, Inc. |
Methods of treating urothelial carcinomas
|
AU2014296288B2
(en)
|
2013-07-31 |
2020-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating thermogenesis using PTH-related and EGF-related molecules
|
US9957506B2
(en)
|
2013-09-25 |
2018-05-01 |
Cornell University |
Compounds for inducing anti-tumor immunity and methods thereof
|
EP2868751A1
(de)
|
2013-10-30 |
2015-05-06 |
Deutsches Krebsforschungszentrum |
HCBI-Sequenzen als früher Marker für die zukünftige Entwicklung von Krebs und Erkrankungen des zentralen Nervensystems, und als Ziel zur Behandlung und Prävention von Krebs
|
WO2015120130A1
(en)
|
2014-02-07 |
2015-08-13 |
Novartis Ag |
Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
CA2944903A1
(en)
|
2014-04-24 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
JP6832709B2
(ja)
|
2014-05-16 |
2021-02-24 |
メディミューン,エルエルシー |
新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
|
EP2966176A1
(de)
|
2014-07-10 |
2016-01-13 |
Deutsches Krebsforschungszentrum |
HCBIO-, MSBI-, MSSI- und CMI-Sequenzen als frühe Marker für die zukünftige Entwicklung von Krebs und Erkrankungen des ZNS und als Ziel zur Behandlung und Prävention dieser Erkrankungen
|
CN106536559B
(zh)
|
2014-07-17 |
2021-04-27 |
诺和诺德股份有限公司 |
定点诱变trem-1抗体以降低黏度
|
WO2016011265A2
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Biomarkers for pin1-associated disorders
|
EP4075139A1
(de)
|
2014-09-11 |
2022-10-19 |
Harry Stylli |
Verfahren zum nachweis von prostatakrebs
|
US20170248603A1
(en)
|
2014-10-06 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Angiopoiten-2 biomarkers predictive of anti-immune checkpoint response
|
EP3204119B1
(de)
|
2014-10-09 |
2021-06-09 |
Dana-Farber Cancer Institute, Inc. |
Mehrfach-variabler il-2-dosierungsplan zur behandlung von immunerkrankungen
|
AU2016229238B2
(en)
|
2015-03-06 |
2022-06-02 |
Dana-Farber Cancer Institute, Inc. |
PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers
|
WO2016145186A1
(en)
|
2015-03-12 |
2016-09-15 |
Beth Israel Deaconess Medical Center, Inc. |
Enhanced atra-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
|
AU2016250849A1
(en)
|
2015-04-24 |
2017-11-02 |
Agena Bioscience, Inc. |
Multiplex methods for detection and quantification of minor variants
|
US10233489B2
(en)
|
2015-04-24 |
2019-03-19 |
Agena Bioscience, Inc. |
Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
|
WO2016176726A1
(en)
|
2015-05-01 |
2016-11-10 |
Griffith University |
Diagnostic methods
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
WO2017123696A1
(en)
|
2016-01-12 |
2017-07-20 |
Interleukin Genetics, Inc. |
Methods for predicting response to treatment
|
WO2017151517A1
(en)
|
2016-02-29 |
2017-09-08 |
Foundation Medicine, Inc. |
Methods of treating cancer
|
JP2019515035A
(ja)
|
2016-04-27 |
2019-06-06 |
ミラ ディーエックス, インコーポレイテッド |
Krasバリアントがん患者の免疫ベースの処置
|
MA45455A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Procédé d'identification d'épitopes peptidiques, molécules qui se lient à de tels épitopes et utilisations associées
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
WO2018005445A1
(en)
|
2016-06-27 |
2018-01-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting and treating diabetes
|
WO2018045162A1
(en)
|
2016-09-01 |
2018-03-08 |
Biogen Ma Inc. |
Biomarkers predictive of primary progressive multiple sclerosis and uses thereof
|
JP7466308B2
(ja)
|
2016-09-20 |
2024-04-12 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Usp10バイオマーカーおよびモジュレーターを用いたamlの同定、評価、予防および処置のための組成物および方法
|
US10337070B2
(en)
|
2017-01-12 |
2019-07-02 |
Cardioforecast Ltd. |
Methods and kits for treating cardiovascular disease
|
WO2018132639A1
(en)
|
2017-01-13 |
2018-07-19 |
Foster Charles Stephen |
Methods and kits for the diagnosis and/or prognosis of ocular cicatricial pemphigoid
|
WO2018226685A2
(en)
|
2017-06-06 |
2018-12-13 |
Dana-Farber Cancer Institute, Inc. |
Methods for sensitizing cancer cells to t cell-mediated killing by modulating molecular pathways
|
CA3080119A1
(en)
*
|
2017-10-27 |
2019-05-02 |
Frontier Diagnostics, Llc |
Mass spectrometry methods for carcinoma assessments
|
WO2019089982A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Method of assessing activity of recombinant antigen receptors
|
SG11202009625WA
(en)
|
2018-04-02 |
2020-10-29 |
Bristol Myers Squibb Co |
Anti-trem-1 antibodies and uses thereof
|
WO2019232460A1
(en)
|
2018-06-01 |
2019-12-05 |
Agena Bioscience, Inc. |
Products and processes for nucleic acid detection and quantification
|
US20210301342A1
(en)
|
2018-09-07 |
2021-09-30 |
Sequenom, Inc. |
Methods, and systems to detect transplant rejection
|
MX2021006234A
(es)
|
2018-11-30 |
2021-09-10 |
Caris Mpi Inc |
Perfilado molecular de proxima generacion.
|
EP3686289A1
(de)
|
2019-01-24 |
2020-07-29 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Cmi-sequenzen als frühmarker für die zukünftige entwicklung von krebs, atherosklerose, diabetes und erkrankungen des zns und als ziel für die behandlung und prävention dieser erkrankungen
|
WO2020172164A1
(en)
|
2019-02-19 |
2020-08-27 |
Sequenom, Inc. |
Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
|
EP3980561A1
(de)
|
2019-06-06 |
2022-04-13 |
Sitokine Limited |
Zusammensetzungen und verfahren zur behandlung von lungen-, kolorektal- und brustkrebs
|
WO2021028469A1
(en)
|
2019-08-12 |
2021-02-18 |
Sitokine Limited |
Compositions and methods for treating cytokine release syndrome and neurotoxicity
|
IL293489A
(en)
|
2019-12-02 |
2022-08-01 |
Caris Mpi Inc |
predictor of pan-cancer platinum response
|
US20230120825A1
(en)
|
2020-02-28 |
2023-04-20 |
Laboratory Corporation Of America Holdings |
Compositions, Methods, and Systems for Paternity Determination
|
WO2021205013A1
(en)
|
2020-04-09 |
2021-10-14 |
Sitokine Limited |
Compositions and methods for treating covid-19
|
CA3212132A1
(en)
|
2021-03-02 |
2022-09-09 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating red blood cell disorders
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
CN113980050B
(zh)
*
|
2021-10-25 |
2023-07-28 |
中元汇吉生物技术股份有限公司 |
一种修饰的核苷酸,组合物及试剂
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
WO2023201226A1
(en)
|
2022-04-11 |
2023-10-19 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for universal tumor cell killing
|
GB202208171D0
(en)
|
2022-06-01 |
2022-07-13 |
Institute Of Cancer Res |
Method
|